Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors-Reference-Cited by-同舟云学术

Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors

Published:2016-01-14 Issue:4 Volume:57 Page:594-600
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Palm Stig,Bäck Tom,Haraldsson Börje,Jacobsson Lars,Lindegren Sture,Albertsson Per

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference24 articles.

1. Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission

2. A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical response;Jacobs;Obstet Gynecol.,1993

3. Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer

4. Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival

5. The potential and hurdles of targeted alpha therapy: clinical trials and beyond;Elgqvist;Front Oncol.,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Behaviour, use and safety aspects of astatine-211 solvated in chloroform after dry distillation recovery;Scientific Reports;2024-04-27

2. Astatine-211 based radionuclide therapy: Current clinical trial landscape;Frontiers in Medicine;2023-01-06

3. Estimating the Risk for Secondary Cancer After Targeted α-Therapy with²¹¹At Intraperitoneal Radioimmunotherapy;Journal of Nuclear Medicine;2022-07-07

4. Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer;Translational Oncology;2021-01

5. Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure;Cancer Biotherapy and Radiopharmaceuticals;2020-08-01